Advertisement

Topics

Companies Related to "Mechanisms Linking Depression to Cardiovascular Risk" [Most Relevant Company Matches] RSS

15:26 EDT 21st August 2018 | BioPortfolio

Here are the most relevant search results for "Mechanisms Linking Depression to Cardiovascular Risk" found in our extensive corporate database of over 50,000 company records.

Showing "Mechanisms Linking Depression Cardiovascular Risk" Companies 1–25 of 1,900+

Relevant

Synvista Therapeutics, Inc.

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione pero...


BrainCells

BrainCells, INC (BCI) is a leading-edge neurogenesis-based drug discovery and development company targeting novel therapies for depression, mood disorders and other CNS diseases. Neurogenesis is emerging as a fundamental mechanism underlying CNS physiology and provides an opportunity for a paradigm-shifting approach to the treatment of CNS disease. BCI believes that, by targeting neurogenesis me...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...


DiagnOptics BV

DiagnOptics is an innovative medical device company based in The Netherlands. The company developed the AGE Reader technology based on findings of scientists and physicians of the Groningen University. We envision DiagnOptics as the world leader in fluorescence-based non-invasive assessment of cardiovascular risk.DiagnOptics developed the AGE Reader, a medical device to estimate cardiovascular ris...

Pivotal Therapeutics Inc.

With offices in Toronto, Canada and Boca Raton, Florida, Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF; CNSX: PVO) specialty pharmaceutical company with a focus on cardiovascular and overall health. Pivotal Therapeutics' lead product VASCAZENTM is a prescription only medical food formulated to meet the dietary Omega-3 deficient needs of patients ...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 38 physicians and 15 mid-level providers in 17 locations, and is one of the largest cardiovasc...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 36 physicians and 14 mid-level providers in 15 locations, and is one of the largest cardiovascu...

Lipoprotein(a) Foundation

Based in San Carlos, California, the Lipoprotein(a) Foundation is a patient-advocacy, 501(c)(3) nonprofit organization. Because approximately 63 million Americans have high lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is to live in a world where high Lipoprotein(a) is routinely diagnosed, treated and fam...

CardioNexus Corporation

CardioNexus Corporation is an affiliated company of Panasonic Healthcare dedicated to reducing cardiovascular disease through early detection and prevention. CardioNexus’ flagship product, the CardioHealth® Station, is a new multi-modality initiative to advance cardiovascular health assessment for the prevention of heart attack and stroke. The advanced, ...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector®, an aortic embolic protection device which acts as a protective shield to reduce the incidence of embolization to the brain, has been granted CE Mark approval. Embrella is a ...

NeuroRx, Inc.

NeuroRx, Inc. is a privately funded, clinical-stage pharmaceutical company, developing NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Ideation and Behavior (ASIB) in bipolar depression. NeuroRx draws upon 30 years of basic science and clinical expertise in the role of the N-methyl-D-aspartate (NMDA), a receptor that regulates human...

Coagulation Diagnostics Incorporated

Coagulation Diagnostics, Inc. (CDI) develops proprietary diagnostic tests for hypercoagulability, or the tendency to form blood clots. The primary applications for the Company's diagnostic tests include monitoring of novel anticoagulants, assessing the risk of acute myocardial infarction, diagnosing possible reactivation of ischemia, and assessing the risk of clotting following invasive cardiovasc...

Midwest Center for Stress and Anxiety

Midwest Center for Stress and Anxiety is the leading provider of self-help and coaching programs for people who suffer from stress, anxiety and depression. Midwest Center specializes in cognitive and behavioral-based solutions that help individuals discover a life of personal fulfillment and purpose. More people use Attacking Anxiety & Depression, Midwest Center's flagship product, to overcome anx...

Aviir Inc.

Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the...

The Risk Authority Stanford

The Risk Authority Stanford (TRA Stanford) is a healthcare risk management consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivaled expertise, and quantifiable results. TRA Stanford’s origins are rooted within the Stanford University Medical Network, and it continues to provide all ...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. We have five product candidates in clinical trials addressing therapeutic indications with significant unmet needs. Our product candidate for insomnia is currently in Phase III clinical trials and o...

Aviir, Inc.

Founded in 2005 by cardiologists and researchers from the Stanford University School of Medicine , Aviir is focused on the discovery, development and commercialization of innovative diagnostic and predictive cardiovascular tests, employing state of the art laboratory diagnostic methods. Aviir’s CLIA laboratory in Irvine, CA offers a range of tests for...

Avedro Inc.

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking and refractive correction. Avedro’s products include capital equipment and related single dose pharmaceuticals. Those products are currently used to enhance Lasik outcomes in a procedure known as Lasik Xtra. Over 75,000 su...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different is our approach to your care.

CV Therapeutics

CV Therapeutics, Inc. (CVT), headquartered in Palo Alto, California, is a biopharmaceutical company focused on the discovery, development, and commercialization of new small molecule drugs for the treatment of cardiovascular diseases. We apply advances in molecular biology and genetics to identify mechanisms of cardiovascular diseases and targets for drug discovery. As a pioneer in the field of m...

Pamlab

Deplin is a prescription medical food for the dietary management of suboptimal L-methylfolate levels in patients with depression. Up to 70 percent of people who suffer from depression may have a specific genetic factor that compromises their ability to convert folic acid into L-methylfolate. L-methylfolate is the only form of folate that can cross the blood brain barrier and regulate serotonin, ...

Origami Risk LLC

Origami Risk LLC was founded by industry veterans committed to designing intuitive web-based software that streamlines how risk, insurance and claims data is collected, analyzed and shared—ultimately helping users to be more productive and manage the total cost of risk for their organizations or for their clients. Origami Risk is consistently ranked b...

The Risk Authority

The Risk Authority – Stanford (TRA) is an innovative healthcare risk management consulting firm dedicated to transforming their clients’ risk management practices with cutting-edge solutions, unrivaled industry expertise and quantifiable results. TRA’s origins are rooted within the Stanford University Medical Network. This connection continues toda...

EPIX Pharmaceuticals

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products through the use of proprietary technology to better diagnose, treat and manage patients. The company has five internally-discovered therapeutic and imaging drug candidates currently in clinical trials targeting conditions such as depression, Alzheimer's disease, ...

Linking Human Systems™

Nil


More From BioPortfolio on "Mechanisms Linking Depression to Cardiovascular Risk"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks